Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.35 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.35 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17244833 | 0.98 | ABCB1 (0.38) | ABCB1SIGMAR1SMN1; SMN2GAAHPGD | |
| SCHEMBL1102294 | 0.91 | ABCB1 (0.43) | ABCB1SIGMAR1SMN1; SMN2HPGDLMNA | |
| SCHEMBL16694832 | 0.90 | ABCB1 (0.41) | ABCB1SMN1; SMN2HPGDLMNANPSR1 | |
| SCHEMBL19208899 | 0.86 | ROCK2 (0.38) | SIGMAR1GAALMNANPSR1ALDH1A1 | |
| SCHEMBL16626228 | 0.85 | ABCB1 (0.39) | ABCB1SIGMAR1SMN1; SMN2HPGDLMNA | |
| SCHEMBL26556073 | 0.84 | HTR1A (0.37) | ABCB1SIGMAR1SMN1; SMN2HPGDLMNA | |
| SCHEMBL17240346 | 0.83 | ABCB1 (0.37) | ABCB1SIGMAR1SMN1; SMN2LMNANPSR1 | |
| SCHEMBL2709792 | 0.83 | HPGD (0.42) | ABCB1SMN1; SMN2HPGDLMNA | |
| SCHEMBL17200830 | 0.81 | ABCB1 (0.40) | ABCB1SIGMAR1SMN1; SMN2GAALMNA | |
| SCHEMBL17529732 | 0.81 | ABCB1 (0.46) | ABCB1SIGMAR1SMN1; SMN2HPGDLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9006491-B2 | Structure and method for synthesizing and using dialkyl(2,4,6- or 2,6-alkoxyphenyl)phosphine and its tetrafluoroborate | ZHEJIANG UNIVERSITY (CN) | 2015-04-14 | — | — | US | disclosed |
| US-20120299468-A1 | HIGH EFFICIENCY YELLOW EMITTERS FOR OLED APPLICATIONS | UNIVERSAL DISPLAY CORPORATION (US) | 2012-11-29 | — | — | US | disclosed |
| US-20120197030-A1 | STRUCTURE AND METHOD FOR SYNTHESIZING AND USING DIALKYL(2,4,6- OR 2,6-ALKOXYPHENYL)PHOSPHINE AND ITS TETRAFLUOROBORATE | ZHEJIANG UNIVERSITY (CN) | 2012-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120197030-A1 | STRUCTURE AND METHOD FOR SYNTHESIZING AND USING DIALKYL(2,4,6- OR 2,6-ALKOXYPHENYL)PHOSPHINE AND ITS TETRAFLUOROBORATE | PTK6, DCLK2, ERBB2 | ABCB1 4589/4885SIGMAR1 3995/4885SMN1; SMN2 4433/4885 |
| US-20120299468-A1 | HIGH EFFICIENCY YELLOW EMITTERS FOR OLED APPLICATIONS | OCIAD1, OCIAD2, JUND | ABCB1 1712/4885SIGMAR1 310/4885SMN1; SMN2 3209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.